BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23978312)

  • 1. Resolution of massive tophaceous gout with three urate-lowering drugs.
    Mejía-Chew C; Torres RJ; de Miguel E; Puig JG
    Am J Med; 2013 Nov; 126(11):e9-10. PubMed ID: 23978312
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment failure gout.
    Ali S; Lally EV
    Med Health R I; 2009 Nov; 92(11):369-71. PubMed ID: 19999896
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in pharmacotherapy for the treatment of gout.
    Robinson PC; Dalbeth N
    Expert Opin Pharmacother; 2015 Mar; 16(4):533-46. PubMed ID: 25547991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
    Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E
    Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database.
    Kim JW; Kwak SG; Park SH
    Korean J Intern Med; 2018 Jan; 33(1):228-229. PubMed ID: 28823114
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical images: Divergent patterns of joint remodeling following effective urate-lowering therapy in tophaceous gout.
    Dalbeth N; Doyle A; McQueen FM
    Arthritis Rheum; 2011 Jan; 63(1):266. PubMed ID: 20722028
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and treatment of gout.
    Meltzler M
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24493155
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Using the whole arsenal to prevent an attack].
    Füeßl HS; Stiefelhagen P
    MMW Fortschr Med; 2015 Nov; 157(20):22. PubMed ID: 26977497
    [No Abstract]   [Full Text] [Related]  

  • 11. Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT).
    Christensen HD; Sheta HM; Morillon MB; Hansen IM
    Am J Case Rep; 2016 Jul; 17():494-8. PubMed ID: 27418121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 13. Major unanswered questions in the clinical gout field.
    Stamp LK
    Curr Opin Rheumatol; 2017 Mar; 29(2):171-177. PubMed ID: 27926541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of the gout and other forms of crystal-induced arthritis.
    Rodnan GP
    Bull Rheum Dis; 1982; 32(5):43-53. PubMed ID: 6762236
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical inquiry: Which prophylactic therapies best prevent gout attacks?
    White S; Mounsey A; Tillett J
    J Fam Pract; 2014 Apr; 63(4):216, 221. PubMed ID: 24905127
    [No Abstract]   [Full Text] [Related]  

  • 16. A challenging case of gout and failure of anti-TNF therapy- are current treatments adequate?
    Nisar MK; Baburaj K
    Int J Rheum Dis; 2011 Aug; 14(3):e42-3. PubMed ID: 21816013
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term management of gout: nonpharmacologic and pharmacologic therapies.
    Chaichian Y; Chohan S; Becker MA
    Rheum Dis Clin North Am; 2014 May; 40(2):357-74. PubMed ID: 24703352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study.
    Richette P; Brière C; Hoenen-Clavert V; Loeuille D; Bardin T
    J Rheumatol; 2007 Oct; 34(10):2093-8. PubMed ID: 17896799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
    Stamp LK; Haslett J; Frampton C; White D; Gardner D; Stebbings S; Taylor G; Grainger R; Kumar R; Kumar S; Kain T; Porter D; Corkill M; Cathro A; Metcalfe S; Wyeth J; Dalbeth N
    Intern Med J; 2016 Sep; 46(9):1075-80. PubMed ID: 27391386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on emerging urate-lowering therapies.
    Chohan S; Becker MA
    Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.